- Applied Clinical Trials-09-01-2023
- Volume 32
- Issue 9
Staying Ahead of the Game
MJH Life Sciences, parent company of Applied Clinical Trials, continues to offer many forms of educational content to healthcare professionals.
Nothing says “end of summer” like high school football practice, apple cider, and Halloween decorations. Everyone packs up their sand chairs and boogie boards and heads back to the classroom, or workplace, whichever is most applicable. Here at MJH Life Sciences®, where education and events go hand-in-hand, our studios have been polished up all summer to bring a series of medical education programs for our physician audience. Titles such as NSCLC Insights, CKD Stakeholder Summit, and Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME, are all intended to help physicians improve their patients’ outcomes.
On the Industry Sciences side, MJH strives to contribute to these efforts in a different way. We inform and educate those professionals who research new compounds, investigate potential therapies in clinical trials, manufacture and distribute these drugs, and who also inform patients and healthcare professionals (HCPs) on the most appropriate ways to take advantage of
innovative drugs.
Here, in addition to events, Industry Sciences offers webcasts, digitally-enhanced “books” and magazines, videos, podcasts, and other forms of educational material for our audiences.
Some current topics that may have relevance to clinical trial professionals when peeking ahead to potential commercial viability, especially those developing hopeful advanced and curative treatments, include:
The American Medical Association
Of course with any large enterprise, complexities abound. This complexity—a constantly evolving and moving target—ensures that learning new information must take precedence for all decision-makers. Please take advantage of our many resources as you head back to work and educate yourself on all the latest issues, challenges, and strategic guidance impacting your decisions.
Thank you for reading.
Mike Hennessy Jr. is the president and CEO of Applied Clinical Trials' parent company, MJH Life Sciences®
Articles in this issue
about 2 years ago
The Pulse of Modeling and Simulation in Clinical Trialsabout 2 years ago
Executing Trial Design With Patients—Not For Patientsabout 2 years ago
Clinical Trial Optionality: Its Reality is Within Reachabout 2 years ago
Trial Participants Are Heroes, Let’s Treat Them That Wayabout 2 years ago
In Search of Attributes Predictive of Collaboration Effectivenessabout 2 years ago
eCOA Systems and Intended Use: Key Considerationsabout 2 years ago
Harnessing the Value of Data Intelligence in Clinical Trialsabout 2 years ago
The Case for Loosening Trial Eligibility Reinsabout 2 years ago
Speeding Up European Clinical Trials in Response to EmergenciesNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.